<DOC>
	<DOCNO>NCT00820586</DOCNO>
	<brief_summary>A randomize study ass safety , feasibility effectiveness direct intramyocardial percutaneous delivery autologous bone marrow-derived total mononuclear cell select CD34+ cell patient refractory angina pectoris .</brief_summary>
	<brief_title>Intramyocardial Delivery Autologous Bone Marrow</brief_title>
	<detailed_description>Primary Endpoint : Incidence major adverse cardiac event ( MACE ) 30 day . MACE define combined endpoint death , acute MI ( Q-wave non-Q wave ) , revascularization procedure ( percutaneous surgical ) , peri-procedural complication ( , leave ventricular perforation hemodynamic consequence require pericardiocentesis , stroke ) . Incidence MACE 3 , 6 12 month Secondary Endpoints : - Change Canadian Cardiovascular Society ( CCS ) angina classification score baseline 12 month - Changes quality life , assess accord Seattle Angina Questionnaire - Change exercise duration exercise tolerance use standardize treadmill exercise test baseline , 6 month 12 month - Cumulative number hospitalization coronary ischemia congestive heart failure 12 month follow treatment . - SPECT-chances global regional radionuclide perfusion rest , peak stress , redistribution baseline 1 , 6 12 month - Change angiographic collateral score 6 month - Change global regional myocardial contractility ( assessed echocardiography ) baseline , 6 12 month .</detailed_description>
	<criteria>Inclusion criterion : 1 . Subjects &gt; 21 year old ; 2 . Subjects functional class ( CCS ) III IV angina ; 3 . Subjects leave ventricular ( LV ) ejection fraction ³ 30 % 4 . Attempted `` best '' tolerate medical therapy 5 . Clinical sign symptom myocardial ischemia reversible ischemia perfusion imaging ; 6 . Patient deem poor candidate high surgical risk ; 7 . Subject must able complete minimum 2 minute 10 minute exercise test ( Bruce Protocol ) ; 8 . Subject ( legal guardian ) understand nature procedure provide write consent prior procedure ; 9 . Subject willing comply specify followup evaluation ; 10 . Patient must develop angina horizontal downsloping STsegment depression ³ 1 mm exercise , compare preexercise ST segment , 80 m J point moderate angina without ST segment change . Angiographic 1 . Severe obstruction ( lumen diameter stenosis &gt; 70 % ) coronary surgical conduit felt solely partially responsible angina myocardial ischemia ; 2 . There must least one coronary surgical conduit &lt; 70 % diameter stenosis 3 . Poor candidate percutaneous coronary intervention treatment zone 4 . Poor candidate surgical revascularization procedure , inadequate target coronary anatomy lack potential surgical conduit . 1 . Pregnant woman ; 2 . Left ventricular ejection fraction &lt; 30 % assess either echocardiography leave ventriculography ; 3 . Severe cardiac heart failure NYHA functional class IIIIV symptom ; 4 . Chronic atrial fibrillation ; 5 . Prosthetic aortic valve ; 6 . Severe ( grade IIIIV ) mitral aortic insufficiency ; 7 . Wall thickness &lt; 8 mm ( defined echocardiography ) propose target region myocardium ; 8 . Severe comorbidity associate reduction life expectancy &lt; 1 year , chronic medical illness 9 . Braunwald class II unstable angina 10 . Severe peripheral ( aortic ) vascular disease might increase risk vascular complication ( perforation , dissection embolization ) ; 11 . Significant aortic valve pathologic sclerosis stenosis 12 . LV thrombus ( mobile muralbased ) see echocardiography ; 13 . Recent ( within 4 week ) document myocardial infarction ( Q and/or nonQ wave ) define CKMB &gt; 3times upper normal level ; 14 . Currently enrol another investigational device drug trial complete required followup period ; 15 . Thrombocytopenia history heparininduced thrombocytopenia thrombocytosis 16 . Leukopenia 17 . Leukocytosis 18 . Anemia erythrocytosis 19 . Active peptic ulcer active gastrointestinal bleeding ; 20 . Chronic renal failure require dialysis ; 21 . Prior current malignancy 22 . Other condition significantly affect bonemarrow 23 . Evidence concurrent infection ( WBC &gt; 12.000 mm3 , temperature &gt; 38.5° C ) ; 24 . Serological clinical evidence HIV 25 . Immunotherapy 26 . Abnormal bonemarrow morphology evident bonemarrow smear prior intervention Angiographic/Ventriculographic 1 . LV thrombus ( mobile muralbased ) see leave ventriculography ; 2 . Coronary lesion suitable percutaneous coronary intervention ; 3 . Unprotected leave main coronary artery disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Intramyocardial</keyword>
	<keyword>Autologous</keyword>
	<keyword>Bone</keyword>
	<keyword>Marrow</keyword>
	<keyword>Randomized</keyword>
	<keyword>Percutaneous</keyword>
	<keyword>CD34+</keyword>
	<keyword>Refractory</keyword>
	<keyword>Angina</keyword>
	<keyword>Pectoris .</keyword>
</DOC>